Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Double Blind Comparative Study of Pain During and After MAL or 5-ALA Photodynamic Therapy
2005-005171-14Phase 4Terminated
- Sponsor
- NHS Tayside
- Start
- Oct 2007
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Bowen disease (BD) and actinic keratosis (AK) comparing MAL photodynamic therapy with 5-ALA photodynamic therapy (2 arms). Primary endpoint: Pain score immediately post treatment. Started Oct 2007; status: terminated.
02
Drugs
methyl aminolevulinate5-aminolevulinic acid
03
Conditions
Bowen disease (BD)actinic keratosis (AK)
Beyond the preview
Go deeper on 2005-005171-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005171-14.